NCT04445701 Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT04436029 Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy Status COMPLETED Phase PHASE2
NCT04432818 Digital Life Coaching for Myeloma Patients Undergoing Transplantation Status COMPLETED Phase NA
NCT04412889 A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory MM Status UNKNOWN Phase EARLY_PHASE1
NCT04405167 Tasquinimod for the Treatment of Relapsed or Refractory Myeloma Status TERMINATED Phase PHASE1
NCT04398745 A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04398680 A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function Status WITHDRAWN Phase PHASE1
NCT04394650 A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT04392037 Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04379817 Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients Status COMPLETED Phase PHASE2
NCT04376957 Pilot Study of an Oral Chemotherapy Teaching Tool to Improve Adherence in Patients With Multiple Myeloma Status UNKNOWN Phase NA
NCT04354246 COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT04349358 FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM) Status RECRUITING Phase NA
NCT04322292 A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma Status COMPLETED Phase PHASE1